DK164547C - Imidazoliumsalte til brug ved saenkning af blodsukkerniveauet hos pattedyr og farmaceutiske praeparater indeholdende saadanne salte - Google Patents

Imidazoliumsalte til brug ved saenkning af blodsukkerniveauet hos pattedyr og farmaceutiske praeparater indeholdende saadanne salte

Info

Publication number
DK164547C
DK164547C DK515285A DK515285A DK164547C DK 164547 C DK164547 C DK 164547C DK 515285 A DK515285 A DK 515285A DK 515285 A DK515285 A DK 515285A DK 164547 C DK164547 C DK 164547C
Authority
DK
Denmark
Prior art keywords
salts
mammals
blood sugar
pharmaceutical preparations
sugar level
Prior art date
Application number
DK515285A
Other languages
Danish (da)
English (en)
Other versions
DK164547B (da
DK515285D0 (da
DK515285A (da
Inventor
Samuel James Dominianni
Terence T T Yen
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK515285D0 publication Critical patent/DK515285D0/da
Publication of DK515285A publication Critical patent/DK515285A/da
Publication of DK164547B publication Critical patent/DK164547B/da
Application granted granted Critical
Publication of DK164547C publication Critical patent/DK164547C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK515285A 1984-11-13 1985-11-08 Imidazoliumsalte til brug ved saenkning af blodsukkerniveauet hos pattedyr og farmaceutiske praeparater indeholdende saadanne salte DK164547C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/670,776 US4609670A (en) 1984-11-13 1984-11-13 Imidazolium hypoglycemic agents
US67077684 1984-11-13

Publications (4)

Publication Number Publication Date
DK515285D0 DK515285D0 (da) 1985-11-08
DK515285A DK515285A (da) 1986-05-14
DK164547B DK164547B (da) 1992-07-13
DK164547C true DK164547C (da) 1992-11-30

Family

ID=24691822

Family Applications (1)

Application Number Title Priority Date Filing Date
DK515285A DK164547C (da) 1984-11-13 1985-11-08 Imidazoliumsalte til brug ved saenkning af blodsukkerniveauet hos pattedyr og farmaceutiske praeparater indeholdende saadanne salte

Country Status (21)

Country Link
US (1) US4609670A (xx)
EP (1) EP0182533B1 (xx)
JP (1) JPH0647576B2 (xx)
KR (1) KR880001231B1 (xx)
CN (1) CN1013444B (xx)
AR (1) AR244671A1 (xx)
AT (1) ATE46505T1 (xx)
AU (1) AU574532B2 (xx)
CA (1) CA1266673A (xx)
DE (1) DE3573114D1 (xx)
DK (1) DK164547C (xx)
EG (1) EG17707A (xx)
ES (1) ES8702370A1 (xx)
GR (1) GR852707B (xx)
HU (1) HU195490B (xx)
IE (1) IE59093B1 (xx)
NZ (1) NZ214088A (xx)
PH (1) PH21656A (xx)
PT (1) PT81439B (xx)
SU (1) SU1424733A3 (xx)
ZA (1) ZA858499B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2210684C (en) * 1995-01-18 2008-01-15 Alteon Inc. Use of thiazolium compounds for preventing and reversing the formation of advanced glycosylation endproducts
US5656261A (en) * 1995-01-18 1997-08-12 The Picower Institute For Medical Research Preventing and reversing advanced glycosylation endproducts
NO315930B1 (no) * 1995-01-18 2003-11-17 Picower Inst For Medical Res T Anvendelse av tiazoliumforbindelser ved fremstilling av farmasöytiske preparater, preparater som inneholder forbindelsene, samt nyetiazoliumforbindelser
US20040198795A1 (en) * 1996-05-08 2004-10-07 Wagle Dilip R Substituted imidazoliums and methods of use therefor
US6121300A (en) * 1998-11-10 2000-09-19 Wagle; Dilip R. Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts
US6781039B2 (en) * 2002-05-07 2004-08-24 Stine Seed Farm, Inc. Soybean cultivar S010360
DE102006028264B4 (de) * 2006-01-10 2008-12-11 Uwe Pisching Sägebock
CN100460395C (zh) * 2006-07-06 2009-02-11 云南大学 芳环和杂环酰甲基咪唑盐类化合物及其制备方法
EP3064204A1 (en) * 2010-03-01 2016-09-07 GTx, Inc. Compounds for treatment of cancer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852301A (en) * 1973-06-21 1974-12-03 Squibb & Sons Inc Enol betaines of imidazoles
US4017631A (en) * 1974-11-19 1977-04-12 Janssen Pharmaceutica N.V. Imidazolium salts
GB1533706A (en) * 1976-03-01 1978-11-29 Ici Ltd Fungicidal imidazoles and 1,2,4-triazoles
DE2643563A1 (de) * 1976-09-28 1978-03-30 Bayer Ag Alpha-(4-biphenylyl)-benzyl-azolium- salze, verfahren zu ihrer herstellung sowie ihre verwendung zur bekaempfung von mikroorganismen
DE2714290A1 (de) * 1977-03-31 1978-10-05 Bayer Ag Fungizide mittel
JPS5479278A (en) * 1977-12-05 1979-06-25 Nippon Soda Co Ltd Imidazolium halide
JPS58150567A (ja) * 1982-03-03 1983-09-07 Kissei Pharmaceut Co Ltd 新規な１，３−二置換イミダゾ−ル誘導体およびその製造方法
US4581370A (en) * 1983-07-12 1986-04-08 Schering A.G. Antiarrhythmic imidazoliums

Also Published As

Publication number Publication date
AR244671A1 (es) 1993-11-30
KR860004029A (ko) 1986-06-16
EP0182533A2 (en) 1986-05-28
CA1266673A (en) 1990-03-13
IE852822L (en) 1986-05-13
JPH0647576B2 (ja) 1994-06-22
AU4973785A (en) 1986-05-22
ATE46505T1 (de) 1989-10-15
PH21656A (en) 1988-01-13
IE59093B1 (en) 1994-01-12
DK164547B (da) 1992-07-13
CN1013444B (zh) 1991-08-07
EG17707A (en) 1990-08-30
GR852707B (xx) 1986-03-10
ES8702370A1 (es) 1987-01-01
DK515285D0 (da) 1985-11-08
AU574532B2 (en) 1988-07-07
KR880001231B1 (ko) 1988-07-12
NZ214088A (en) 1988-09-29
DE3573114D1 (en) 1989-10-26
PT81439A (en) 1985-12-01
SU1424733A3 (ru) 1988-09-15
PT81439B (pt) 1988-03-03
US4609670A (en) 1986-09-02
HU195490B (en) 1988-05-30
DK515285A (da) 1986-05-14
ZA858499B (en) 1987-06-24
EP0182533B1 (en) 1989-09-20
ES548797A0 (es) 1987-01-01
HUT39164A (en) 1986-08-28
CN85108115A (zh) 1986-07-30
EP0182533A3 (en) 1987-06-03
JPS61122212A (ja) 1986-06-10

Similar Documents

Publication Publication Date Title
DK333788A (da) Farmaceutisk praeparat til behandling af oedelagt bruskvaev
DK99086A (da) Farmaceutiske praeparater til behandling af hukommelsesforstyrrelser
PT87133A (pt) Method of purification of leukaemia inhibitory factor (lif) and of pharmaceutical compounds containing polypeptides with activity of the lif
DK170187D0 (da) Pharmaceutisk fordelagtigt salt af amlodipin og farmaceutiske praeparater indeholdende dette
BR8403186A (pt) Lamina aperfeicoada de relha
DK51493A (da) Laegemiddel indeholdende humant interleukin-1alfa og anvendelse af interleukin-1alfa til fremstilling af et saadant laegemiddel
DK164547C (da) Imidazoliumsalte til brug ved saenkning af blodsukkerniveauet hos pattedyr og farmaceutiske praeparater indeholdende saadanne salte
DK127588A (da) Beta-aminoethylsubstituerede phenylforbindelser, farmaceutiske praeparater indeholdende samme og fremgangsmaader til fremstilling af saadanne forbindelser
DK226488A (da) Anvendelse af ace-inhibitorer til fremstilling af farmaceutiske praeparater
DK253688A (da) Laegemiddel til brug ved behandling af atherosclerose
DK712388A (da) Heterocyclisk substituerede oxo- eller thiophthalazinyl-eddikesyre-forbindelser og farmaceutiske praeparater indeholdende disse
DK425287D0 (da) Fremstilling af et farmaceutisk praeparat til behandling af kongestivt hjertesvigt
DK4487A (da) Heterocycliske forbindelser og farmaceutiske praeparater indeholdende disse
NO854227L (no) Fralands plattformkonstruksjon av armert betong og fremgangsmaate ved fremstilling av samme.
DK93385D0 (da) 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoliner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
DK240984A (da) 5-(4-chlor-3-sulfamoylbenzoyl)-2,3-dihydro-2-benzofurancarboxylsyrer, fremgangsmaader til deres fremstilling samt farmaceutiske praeparater indeholdende disse
DK369088D0 (da) Fremgangsmaade til fremstilling af nukleinsyrederivater og fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende disse
DK438186A (da) Fremgangsmaade til fremstilling af ved oxygenet beskyttede glycosylfluorider
NO168581C (no) Fremgangsmaate ved fremstilling av terapeutisk aktive beta-methylen-thiofenethanaminer
DK701588D0 (da) N-hydroxy-5-phenyl-2-furancarboximidamider og anvendelse heraf til fremstilling af farmceutiske praeparater
DK489084D0 (da) Fremgangsmaade til udvinding af beta-elemonsyre og farmaceutisk praeparat indeholdende beta-elemonsyre
DK365087A (da) 1,3,5-trithianderivater, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
DK213988D0 (da) Dihydropyridinforbindelser samt medisinsk anvendelse af disse og beslaegtede forbindelser og farmaceutiske praeparater indholdende disse.
DK328087D0 (da) N-imidazolylmethyl-diphenylazomethiner samt fremgangsmaade til fremstilling af saadanne forbindelser og anvendelse af disse i farmaceutiske praeparater
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet

Legal Events

Date Code Title Description
PBP Patent lapsed